Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia - a case report

Osawa, Eduardo Atsushi; Brandão, Antonio Adolfo Guerra Soares; Américo, André Dias; Maciel, Alexandre Toledo.
Hematol., Transfus. Cell Ther. (Impr.) ; 44(1): 108-111, Jan.-Mar. 2022. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1364879

Documentos relacionados

  1. Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration.
  2. HIT the price point with fondaparinux.
  3. Heparin-induced thrombocytopenia: a case report and literature overview.
  4. The Year in Coagulation and Transfusion: Selected Highlights from 2022.
  5. The Predictive Value of the 4Ts and HEP Score at Recommended Cutoffs in Patients With Mechanical Circulatory Support Devices.
  6. Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients.
  7. Heparin-induced thrombocytopenia after switching from unfractionated heparin to low-molecular-weight heparin: A case report and literature review.
  8. Heparin-induced thrombocytopenia post-cardiovascular interventional therapy: a case report.
  9. The Impact of an Antithrombotic Stewardship Program on Heparin-Induced Thrombocytopenia Management.
  10. Clinical decision support to reduce unnecessary diagnostic testing for heparin-induced thrombocytopenia.